Avalyn Pharma Inc. Common Stock (AVLN) Stock Overview
Explore Avalyn Pharma Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Avalyn Pharma Inc. Common Stock (AVLN)
Key Financials
Key Financials
Market Cap
1.4B
P/E Ratio
-24.96
EPS (TTM)
$-2.33
ROE
-0.83%
AVLN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Avalyn Pharma Inc. Common Stock (NASDAQ: AVLN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Avalyn Pharma Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AVLN on the NASDAQ shows an RSI of 38.41, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Avalyn Pharma Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -24.96 and a market capitalization of 1.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AVLN on the NASDAQ.